An over-the-counter drug could help prevent severe complications — but a lot more study is needed.
Diana Duong
Diana’s work has appeared in Maclean’s, Reader’s Digest, The Globe and Mail, Huffington Post, The Medical Post, and Flare, among other publications. Before joining Healthing, she was a medical storyteller at Figure 1 and an assistant editor and head of research at Chatelaine, Canada’s largest women’s media brand.
Articles By Diana Duong
-
Could aspirin help hospitalized COVID patients?
-
How to help your mood this winter under the cloud of COVID-19 How to help your mood this winter under the cloud of COVID-19
With our first full winter under COVID-19 lockdown, seasonal affective disorder could be amplified this season.
-
'It hurts to be alive': Stories from COVID-19 long-haulers 'It hurts to be alive': Stories from COVID-19 long-haulers
For thousands of people who have had COVID-19, the disease never left.
-
Chinese COVID-19 vaccine shows early promise Chinese COVID-19 vaccine shows early promise
Study shows Sinopharm's BBIBP-CorV vaccine creates an antibody response against the virus.
-
COVID-19: What we know about heating, cooling and ventilation COVID-19: What we know about heating, cooling and ventilation
As the colder weather looms, preventing transmission indoors will be a combination of hygiene, distancing and proper ventilation.
-
New insight into why more men are dying of COVID than women New insight into why more men are dying of COVID than women
According to the World Health Organization, 56 per cent of worldwide COVID-19 deaths have been in men
-
Empathy key in battling COVID-19: study Empathy key in battling COVID-19: study
Researchers also found sharing real stories from people vulnerable to COVID-19 induced more empathy than guidelines
-
Biden vs. Trump: masks, vaccines and mistakes Biden vs. Trump: masks, vaccines and mistakes
Trump said he's 'good' with masks, but spreads misinformation during town hall
-
Gene therapy approved to restore vision for genetically blind Gene therapy approved to restore vision for genetically blind
Luxturna is the first gene therapy treatment approved in Canada, but without provincial funding, it comes at a high cost
-
People with Type O less likely to test positive for COVID-19 People with Type O less likely to test positive for COVID-19
Researchers found people with Type A blood had increased risk for respiratory failure.